TC-83 vaccine protects against airborne or subcutaneous challenge with heterologous mouse-virulent strains of Venezuelan equine encephalitis virus

Vaccine

Volumn 17, Issue 7-8, 1999, Pages 982-988

  Phillpotts, R J ^a   Wright, A J ^a  

^a DERA   (United Kingdom)

Author keywords

Airborne infection; Vaccine; Venezuelan equine encephalitis virus

Indexed keywords

ENCEPHALITIS VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; TC 83 VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

AIRBORNE INFECTION; ANTIGEN SPECIFICITY; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; MOUSE; NONHUMAN; OLFACTORY NERVE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION; WESTERN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; ZOONOSIS;

ANIMALS; ANTIBODIES, VIRAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; ENCEPHALOMYELITIS, VENEZUELAN EQUINE; FEMALE; IMMUNOGLOBULIN A, SECRETORY; MICE; NEUTRALIZATION TESTS; VIRAL VACCINES; VIRULENCE;

EID: 0033605098     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00315-6     Document Type: Article

References (30)

1. Pederson C.E., Eddy E.A. Separation, isolation and immunochemical studies of the structural proteins of Venezuelan equine encephalalomyelitis virus. J Virol. 14:1974;740-744.
2. France J.K., Wyrick B.C., Trent D.W. Biochemical and antigenic comparisons of the envelope glycoproteins of Venezuelan equine encephalalomyelitis virus strains. J Gen Virol. 44:1979;725-740.
3. Kinney R.M., Trent D.W., France J.K. Comparative biochemical and immunological analyses of viruses in the Venezuelan equine encephalitis virus complex. J Gen Virol. 64:1983;135-147.
4. Rivas F., Diaz L.A., Cardenas V.M., et al. Epidemic Venezuelan encephalitis in La Guajira, Colombia, 1995. J Infect Dis. 175:1997;828-832.
5. Johnson K.M., Martin D.H. Venezuelan equine encephalitis. Adv Vet Sci Comp Med. 18:1974;79-116.
6. McKinney R.W. Inactivated and live VEE vaccines-a review. In: Venezuelan encephalitis, Scientific Publication no. 243, Washington, DC. American Health Organisation, 1972. p. 369-376.
7. Walton T.E., Alvarez O., Buckwalter R.M., Johnson K.M. Experimental infection of horses with an attenuated venezuelan equine encephalomyelitis vaccine (strain TC-83). Infect Immun. 5:1972;750-756.
8. Eddy G.A., Martin D.H., Reeves W.C., Johnson K.M. Field studies of an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83). Infect Immun. 5:1972;160-163.
9. Berge T.O., Banks I.S., Tigertt W.D. Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea pig heart cells. Am J Hyg. 73:1961;209-218.
10. Mathews J.H., Roehrig J.T., Trent D.W. Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan eqiune encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies. J Virol. 55:1985;594-600.
11. Scmaljohn A.L., Johnson E.D., Dalrymple J.M., Cole G.A. Non-neutralising monoclonal antibodies can prevent lethal alphavirus encephalitis. Nature. 297:1982;70-72.
12. Jahrling P.B., Stephenson E.H. Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters. J Clin Microbiol. 19:1984;429-431.
13. Hart M.K., Pratt W., Panelo F., Tamariello R., Dertzbaugh M. Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in Balb/c but not C3H/HeN mice. Vaccine. 15:1997;363-369.
14. Phillpotts R.J., Brooks T.M., Cox C.S. A simple device for the exposure of animals to infectious microorganisms by the airborne route. Epidem Infect. 118:1997;71-75.
15. Wright A.W., Phillpotts R.J. Humane endpoints are an objective measure of morbidity in Venezuelan encephalomyelitis virus infection of mice. Arch Virol. 141:1998;743-749.
16. Phillpotts R.J., Venugopal K., Brooks T. Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virus. Archives of Virology. 141:1995;743-749.
17. Eyles J.E., Sharp G.J.E., Williamson E.D., Spiers I.D., Alpar O.A. Intranasal administration of poly-lactic acid microsphere c0-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse. Vaccine. 16:1998;698-707.
18. Self C.H. Enzyme amplification - a general method applied to provide an immunoassisted assay for placental alkaline phosphatase. J Immunol Meth. 76:1985;389-393.
19. Stanley C.J., Johannsson A., Self C.H. Enzyme amplification can enhance both the speed and the sensitivity of immunoassays. J Immunol Meth. 83:1985;89-95.
20. Karber G. Beitrag zur kollectiven Behandlung pharmakolischer Reihenversuche. Archiv fur Exp Path Pharm. 162:1931;480-483.
21. London W.T., Levitt N.H., Kent S.G., Wong V.G., Sever J.L. Congenital cerebral and ocular malformations induced in rhesus monkeys by Venezuelan equine encephalitis virus. Teratology. 16:1977;285-296.
22. Bowen G.S., Rafield E.J., Monath T.P., Kemp G.E. Studies in glucose metabolism in rhesus monkeys after Venezuelan equine encephalitis virus infection. J Med Virol. 6:1980;227-234.
23. Jahrling P.B., Stephenson E.H. Protective efficacies of live attenuated and formaldehyde inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters. J Clin Microbiol. 19:1984;429-431.
24. Burke D.S., Ramsburg H.H., Edelmann R. Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunisation with attenuated (TC-83) VEE virus vaccine. J Infect Dis. 136:1977;354-356.
25. Franck P. Round table on epidemic control. In: Venezuelan encephalitis, Scientific Publication no. 243. Washington, DC, American Health Organisation, 1972. p. 400-401.
26. Coutelier J-P., Van der Logt J.T.M., Hessen F.W.A., et al. IgG2a restriction of murine antibodies elicited by viral infections. J Exp Med. 165:1987;64-69.
27. Charles P.C., Walters E., Margolis F., Johnston Re. Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse. Virol. 208:1995;662-671.
28. Vogel P., Abplanalp D., Kell W., Ibrahim M.S., Downs M.B., Pratt W.D., Davis K.J. Venezuelan equine encephalitis in Balb/c mice. Archives of Pathology and Laboratory Medicine. 120:1996;164-172.
29. Ryzhikov A.B., Tkacheva N.V., Sergeev A.N., Rybchikova E.I. Venezuelan equine encephalitis virus propagation in the olfactory tract of normal and immunised mice. Biomed Sci. 2:1991;607-614.
30. Ryzhikov A.B., Rybchikova E.I., Sergeev A.N., Tkacheva N.V. Spread of Venezuelan equine encephalitis virus in mice olfactory tract. Arch Virol. 140:1995;2243-2254.